关键词：下一代测序；DNA小片段；毛细管电泳；发射信号顺序；模板链；高尖端仪器
摘 要：NGS technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis, where the bases of a small fragment of DNA are sequentially identified from signals emitted and each fragment is resynthesized from a DNA template strand. The major difference is the NGS process is extended across millions of reactions in a parallel fashion rather than being restricted to a single or a few DNA fragments. NGS technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole-genome, exome, and transcriptome sequencing. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Genome Sequencing Cost Analysis

08. Cost of Equipment

09. Reimbursement and Coverage

10. Regulatory Point of View for NGS Tests

10.1 Analytical Performance of NGS Tests

10.2 Accessing Clinical Performance of NGS Tests

10.2.1 Leveraging Genetic Databases to Evaluate Clinical

Performance

10.2.2 Communicate Information about Less Well-known Variants

11. Market Segmentation by Product

11.1 Global NGS Market by Product 2014-2019

11.2 Global NGS Market by Reagents and

Consumables

11.2.1 Market Size and Forecast

11.3 Global NGS Market by Equipment

11.3.1 Market Size and Forecast

12. Market Segmentation by End-user

12.1 Global NGS Market by End-user 2014-2019

13. Market Segmentation by Technology

13.1 Global NGS Market by Technology

13.1.1 Sequencing by Synthesis

13.1.2 Ion Semiconductor Sequencing

13.1.3 Sequencing by Ligation

13.1.4 Pyrosequencing

13.1.5 SMRT Sequencing

14. Geographical Segmentation

14.1 Global NGS Market by Geographical

Segmentation 2014-2019

14.2 NGS Market in Americas

14.2.1 Market Size and Forecast

14.3 NGS Market in EMEA

14.3.1 Market Size and Forecast

14.4 NGS Market in APAC

14.4.1 Market Size and Forecast

15. Buying Criteria

16. Market Growth Drivers

17. Drivers and their Impact

18. Market Challenges

19. Impact of Drivers and Challenges

20. Market Trends

21. Trends and their Impact

22. Vendor Landscape

22.1 Competitive Scenario

22.1.1 Key News

22.1.2 Mergers and Acquisitions

22.2 Market Share Analysis 2014

22.3 Other Prominent Vendors

23. Key Vendor Analysis

23.1 Illumina

23.1.1 Key Facts

23.1.2 Business Overview

23.1.3 Business Segmentation

23.1.4 Geographical Segmentation by Revenue 2013

23.1.5 Business Strategy

23.1.6 Key Information

23.1.7 SWOT Analysis

23.2 Roche Diagnostics

23.2.1 Key Facts

23.2.2 Business Overview

23.2.3 Business Segmentation by Revenue 2013

23.2.4 Geographical Segmentation by Revenue 2013

23.2.5 Business Strategy

23.2.6 Key Developments

23.2.7 SWOT Analysis

23.3 Life Technologies now part of Thermo Fisher

Scientific

23.3.1 Key Facts

23.3.2 Business Overview

23.3.3 Business Segmentation by Revenue 2012

23.3.4 Geographical Segmentation by Revenue 2012

23.3.5 Business Strategy

23.3.6 Recent Developments

23.3.7 SWOT Analysis

24. Other Reports in this Series